Drug Interactions

Key Points

• Drug interactions occur when one drug alters the effect of another through pharmacokinetic or pharmacodynamic mechanisms.
• Pharmacokinetic interactions affect absorption, distribution, metabolism, or excretion of a drug.
• Pharmacodynamic interactions involve additive, synergistic, or antagonistic effects at the receptor or physiologic level.
• Polypharmacy, especially in older adults, significantly increases drug interaction risk.
• Nurse assessment of complete medication lists (including OTC and herbal supplements) is essential for interaction prevention.
• Complementary and alternative therapies can potentiate, negate, or toxically overlap prescribed medications and require proactive screening.

Pathophysiology

Drug interactions can occur at any stage of pharmacokinetics (what the body does to the drug) or pharmacodynamics (what the drug does to the body).

Pharmacokinetic Interactions

• Absorption: One drug may alter GI pH, motility, or chelate another drug, reducing absorption (for example, antacids reducing fluoroquinolone absorption).
• Distribution: Protein-binding displacement can increase free drug concentration (for example, warfarin displaced by NSAIDs).
• Metabolism: Cytochrome P450 enzyme induction or inhibition is the most common mechanism. Inhibitors (grapefruit juice, ketoconazole) increase drug levels; inducers (rifampin, carbamazepine) decrease drug levels.
• Excretion: Changes in renal pH or tubular secretion can alter drug elimination rates.

Pharmacodynamic Interactions

• Additive: Combined effect equals the sum of individual effects (for example, two CNS depressants).
• Synergistic: Combined effect greater than the sum of individual effects (for example, trimethoprim-sulfamethoxazole).
• Antagonistic: One drug reduces or blocks the effect of another (for example, naloxone reversing opioid effects).

Common CAM Interaction Alerts

• Bleeding risk amplification: Garlic, ginger, turmeric, and chamomile can increase bleeding tendency when combined with anticoagulants or antiplatelets.
• Enzyme and efficacy interactions: St. John’s wort can reduce effectiveness of medications such as hormonal contraceptives, digoxin, theophylline, and selected anticancer therapies while also interacting with antidepressants.
• Cardiovascular interaction risk: Hawthorn can potentiate effects of digoxin, ACE inhibitors, and CNS depressants.
• Neuropsychiatric interaction risk: Ginseng may interact with MAOIs and caffeine-heavy intake, increasing irritability and adverse-effect burden.
• Sedation and hepatic caution: Valerian can cause excess sedation with CNS depressants and has liver-toxicity concern in prolonged unsupervised use.

High-Risk Oncology Interaction Alert

• Tamoxifen with coumarin-type anticoagulants: Concomitant use can increase anticoagulation risk; review alternatives or intensify INR and bleeding surveillance.

Nursing Assessment

NCLEX Focus

Always assess the complete medication list (prescription, OTC, herbal, dietary supplements) to identify potential interactions before administering any new medication.

• Obtain a comprehensive medication history including prescriptions, over-the-counter drugs, herbal supplements, and dietary habits.
• Identify high-risk drug combinations (for example, warfarin with NSAIDs, MAOIs with tyramine-rich foods, Nitrates with PDE5 inhibitors).
• Ask specifically about herbal products by name (not only “supplements”) because patients may not classify teas, powders, or traditional remedies as medications.
• Assess for polypharmacy in older adults; more medications increase interaction probability.
• Monitor for signs of increased drug toxicity or decreased therapeutic effect after medication changes.
• Verify drug interactions using current evidence-based references before administering unfamiliar combinations.

Nursing Interventions

• Maintain an accurate, current medication list for every client.
• Use pharmacy consultation and electronic interaction-checking systems for complex medication regimens.
• Time medication administration appropriately to minimize absorption interactions (for example, space iron and antacids by 2 hours).
• Educate clients about food-drug interactions (grapefruit, dairy, alcohol, tyramine-rich foods).
• Teach high-risk herb-drug examples and advise clients to report all CAM products before starting, stopping, or changing prescription drugs.
• Report and document suspected adverse drug interactions promptly.
• Advocate for medication reconciliation at every care transition (admission, transfer, discharge).

Related Concepts

• medication-administration-safety-measures - Broader medication error prevention context.
• geriatric-assessment-and-polypharmacy-safety - Multiple medication use and interaction risk.
• Pharmacokinetics - Drug absorption, distribution, metabolism, and excretion framework.
• nsaids - Commonly involved in drug interaction scenarios.
• anticoagulants - High interaction potential requiring careful monitoring.

Self-Check

1. What is the most common mechanism for pharmacokinetic drug interactions?
2. How does an enzyme inducer differ from an enzyme inhibitor in terms of drug levels?
3. Why is medication reconciliation critical at every care transition point?